Buscar
Congreso SOLACI
HomeInternational CongressesESC 2012

ESC 2012

Ver Categoría
Day 2

GRACE: Use of insulin glargine and fatty acids to reduce atherosclerosis progression.

Presentation Summary: There is a clear association between hyperglycemia and the development of atherosclerosis. The GRACE sub...
solaci -
Ver más
Day 2

GARY: German Aortic Valve Registry.

Presentation Summary: The German Aortic Stenosis Registry collected data from German centers. 13,860 patients who were undergoing...
solaci -
Ver más
Day 2

FAST MI: AMI improved the survival associated with the clinical characteristics changes of patients in the French National Registry.

Presentation Summary: The French National Registry included patients admitted with acute myocardial infarction between 1995 and 2010...
solaci -
Ver más
Day 2

IABP-SHOCK II: Intra-aortic balloon use impact on 30-day mortality in patients with cardiogenic shock.

 IABP-SHOCK II: Intra-aortic balloon use impact on 30-day mortality in patients with cardiogenic shock. Holger Thiele2012-08-26Original title: IABP-SHOCK II:...
solaci -
Ver más
Day 2

PROTECT: A comparison of thrombosis incidence between the drug-eluting stents sirolimus and zotarolimus.

Summary: Randomized, open, pragmatic essay PROTECT (patient related outcomes of Endeavor versus Cypher stenting trial) compared two...
solaci -
Ver más
Day 1

DeFACTO: Diagnostic Precision of CT Angiography in Determining FFR.

 DeFACTO: Diagnostic Precision of CT Angiography in Determining FFR.  Read articleJames K. Min2012-08-25
solaci -
Ver más
Day 1

PURE: This study shows different patterns of cardiovascular risk factor prevalence in countries with different socio-economical background, and recommends individualized intervention..

Presentation Summary: The Prospective Urban Rural Epidemiologic (PURE) study evaluated 153996 people from different countries and different...
solaci -
Ver más
Day 1

ALTITUDE: Aliskiren Trial In Type 2 Diabetes Using Cardio Renal Endpoints.

Editorial Comment: Morbimortality in diabetic patients is still a matter of deep concern in the context of...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad